Investors / Canada / Cross-Border Impact Ventures
Cross-Border Impact Ventures
Venture capital · Toronto, ON, Canada · North America
Cross-Border Impact Ventures is an impact venture capital firm that invests in companies commercializing medical devices, diagnostics, therapeutics and digital health innovations. It focuses on health technologies for women, children and adolescents, and supports management teams with access to new markets and capital in North America, Europe and global markets.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordshealthtechwomen's healthmaternal healthpediatric healthdigital healthimpact investing
Your fit with Cross-Border Impact Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCross-Border Impact Ventures lists 10 checked portfolio companies on its own site and is named in 2 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (82%) and Industrial & Manufacturing (18%). 43% of its companies are based in United Kingdom. It invests most often alongside ATDC, Airstream Venture Partners and Athos Capital.
Counts come from funding rounds that name Cross-Border Impact Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Cross-Border Impact Ventures' whole history. Rounds on record name 2 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundCross-Border Impact Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 92th | 20% of companies confirmed by a round |
| Sector focus | 94th | 82% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ATDC | 1 |
| Airstream Venture Partners | 1 |
| Athos Capital | 1 |
| BGF | 1 |
| BIP Ventures | 1 |
| BayMed Venture Partners | 1 |
| Broadview Ventures | 1 |
| Catalio Capital Management | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 82% | 15% |
| Industrial & Manufacturing | 18% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Cross-Border Impact Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Cross-Border Impact Ventures| Date | Company | Stage |
|---|---|---|
| 24 Jul 2026 | Series A Led | |
| 8 Jan 2026 | Series B Led |
Round details for Cross-Border Impact Ventures
Amounts, full round histories and every co-investor in Cross-Border Impact Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Axena Health is focused on providing innovative new treatments in women’s pelvic health | Healthcare & Biotech | Portfolio page | ||
| The company helps people and animals live better worldwide by supporting the gut microbiome with its Binding Proteins ingredient. | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| Cardiosense develops a heart failure monitoring solution to noninvasively determine Pulmonary Capillary Wedge Pressure at the point of care. | Healthcare & Biotech | Portfolio page | ||
| The company produces and supplies incubators for warming infants, particularly the mOm Essential Incubator, to prevent separation and provide a controlled thermal environment. | Healthcare & Biotech | Portfolio page | ||
| OncoLens harnesses the data from pathology, radiology, and genomics and turns it into action for cancer-focused teams. | Healthcare & Biotech | Portfolio page | ||
| Oxford Cancer Analytics generates evidence-based insights to support clinical decision-making in lung disease, including Chronic Obstructive Pulmonary Disease (COPD) and lung cancer. | Healthcare & Biotech | Portfolio page | ||
| Raydiant Oximetry develops fetal pulse oximetry technologies for labor and delivery | Healthcare & Biotech | Portfolio page | ||
| Sonio provides IT system integration and full service provider solutions, including data management, digital workplace, hybrid cloud, and artificial intelligence services. | Industrial & ManufacturingIndustrial & Manufacturing | Portfolio page | ||
| TidalSense develops and provides respiratory diagnostics and monitoring technologies using AI-driven platforms. | Healthcare & Biotech | Jul 2026Series A | Page + round | |
| Daye offers sustainable period products and gynae health services, including at-home screening kits and consultations with clinicians. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- crossborder.ventures
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Jan 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Cross-Border Impact Ventures' profile as data
Pull Cross-Border Impact Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/crossborder.ventures
# also
GET /v1/firms/crossborder.ventures/portfolio
GET /v1/firms/crossborder.ventures/coinvestors
GET /v1/firms/crossborder.ventures/news